105 related articles for article (PubMed ID: 2412704)
1. Substance P mechanism in cluster headache: evaluation in plasma and cerebrospinal fluid.
Sicuteri F; Fanciullacci M; Geppetti P; Renzi D; Caleri D; Spillantini MG
Cephalalgia; 1985 Sep; 5(3):143-9. PubMed ID: 2412704
[TBL] [Abstract][Full Text] [Related]
2. Substance P and enkephalins: a creditable tandem in the pathophysiology of cluster headache and migraine.
Sicuteri F; Renzi D; Geppetti P
Adv Exp Med Biol; 1986; 198 Pt B():145-52. PubMed ID: 2433912
[TBL] [Abstract][Full Text] [Related]
3. Substance P theory: a unique focus on the painful and painless phenomena of cluster headache.
Sicuteri F; Fanciullacci M; Nicolodi M; Geppetti P; Fusco BM; Marabini S; Alessandri M; Campagnolo V
Headache; 1990 Jan; 30(2):69-79. PubMed ID: 1689282
[TBL] [Abstract][Full Text] [Related]
4. A pharmacological approach to the analgesizing mechanism of somatostatin in cluster headache.
Caleri D; Marabini S; Panconesi A; Pietrini U
Ric Clin Lab; 1987; 17(2):155-62. PubMed ID: 2888182
[TBL] [Abstract][Full Text] [Related]
5. Substance P in the human iris: possible involvement in echothiophate-induced miosis in cluster headache.
Fanciullacci M; Pietrini U; Geppetti P; Nicolodi M; Curradi C; Sicuteri F
Cephalalgia; 1988 Mar; 8(1):49-53. PubMed ID: 2452018
[TBL] [Abstract][Full Text] [Related]
6. Sensory neuropeptides (substance P, calcitonin gene-related peptide) and vasoactive intestinal polypeptide in human saliva: their pattern in migraine and cluster headache.
Nicolodi M; Del Bianco E
Cephalalgia; 1990 Feb; 10(1):39-50. PubMed ID: 1690601
[TBL] [Abstract][Full Text] [Related]
7. A putative 5-HT central feedback in migraine and cluster headache attacks.
Salmon S; Bonciani M; Fanciullacci M; Marianelli L; Michelacci S; Sicuteri F
Adv Neurol; 1982; 33():265-74. PubMed ID: 7055005
[TBL] [Abstract][Full Text] [Related]
8. Nostril capsaicin application as a model of trigeminal primary sensory neuronal activation.
Nicolodi M
Cephalalgia; 1994 Apr; 14(2):134-8. PubMed ID: 7520365
[TBL] [Abstract][Full Text] [Related]
9. Substance P and endogenous opioids: how and where they could play a role in cluster headache.
Sicuteri F; Rainò L; Geppetti P
Cephalalgia; 1983 Aug; 3 Suppl 1():143-5. PubMed ID: 6193886
[TBL] [Abstract][Full Text] [Related]
10. Serum interleukin-1 beta is increased in cluster headache.
Martelletti P; Granata M; Giacovazzo M
Cephalalgia; 1993 Oct; 13(5):343-5; discussion 307-8. PubMed ID: 7694804
[TBL] [Abstract][Full Text] [Related]
11. [Reduced sympathetic nervous system activity during the cluster period of cluster-headache].
Strittmatter M; Hamann GF; Blaes F; Grauer M; Fischer C; Hoffmann KH
Schweiz Med Wochenschr; 1996 Jun; 126(24):1054-61. PubMed ID: 8701243
[TBL] [Abstract][Full Text] [Related]
12. Histamine and serotonin in cluster headache.
Anthony M; Lance JW
Arch Neurol; 1971 Sep; 25(3):225-31. PubMed ID: 4951945
[No Abstract] [Full Text] [Related]
13. Cerebrospinal fluid levels of immunoreactive substance P and somatostatin in patients with multiple sclerosis and inflammatory CNS disease.
Rösler N; Reuner C; Geiger J; Rissler K; Cramer H
Peptides; 1990; 11(1):181-3. PubMed ID: 1692993
[TBL] [Abstract][Full Text] [Related]
14. Substance P in human cerebrospinal fluid: reductions in peripheral neuropathy and autonomic dysfunction.
Nutt JG; Mrox EA; Leeman SE; Williams AC; Engel WK; Chase TN
Neurology; 1980 Dec; 30(12):1280-5. PubMed ID: 6161319
[TBL] [Abstract][Full Text] [Related]
15. Increase in plasma calcitonin gene-related peptide from the extracerebral circulation during nitroglycerin-induced cluster headache attack.
Fanciullacci M; Alessandri M; Figini M; Geppetti P; Michelacci S
Pain; 1995 Feb; 60(2):119-123. PubMed ID: 7540279
[TBL] [Abstract][Full Text] [Related]
16. Elevated cerebrospinal fluid substance P-like immunoreactivity in patients with painful osteoarthritis, but not in patients with rhizopatic pain from a herniated lumbar disc.
Lindh C; Liu Z; Lyrenäs S; Ordeberg G; Nyberg F
Scand J Rheumatol; 1997; 26(6):468-72. PubMed ID: 9433409
[TBL] [Abstract][Full Text] [Related]
17. Cerebrospinal fluid immunoreactive substance P and somatostatin in neurological patients with peripheral and spinal cord disease.
Cramer H; Rösler N; Rissler K; Gagnieu MC; Renaud B
Neuropeptides; 1988 Oct; 12(3):119-24. PubMed ID: 2468107
[TBL] [Abstract][Full Text] [Related]
18. Responsiveness of the trigeminovascular system to nitroglycerine in cluster headache patients.
Fanciullacci M; Alessandri M; Sicuteri R; Marabini S
Brain; 1997 Feb; 120 ( Pt 2)():283-8. PubMed ID: 9117375
[TBL] [Abstract][Full Text] [Related]
19. Studies on nitroglycerin and histamine provoked cluster headache attacks.
Bogucki A
Cephalalgia; 1990 Apr; 10(2):71-5. PubMed ID: 2113833
[TBL] [Abstract][Full Text] [Related]
20. Effects of the substance P antagonist, (D-Arg1, D-Pro2, D-Trp7,9, Leu11)-SP on the miotic response to substance P, antidromic trigeminal nerve stimulation, capsaicin, prostaglandin E1, compound 48/80 and histamine.
Mandahl A; Bill A
Acta Physiol Scand; 1984 Jan; 120(1):27-35. PubMed ID: 6202097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
